- Home
- EFOI vs NLSP Comparison
EFOI vs NLSP Comparison
Compare EFOI & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFOI
- NLSP
- Stock Information
- Founded
- EFOI 1985
- NLSP 2015
- Country
- EFOI United States
- NLSP Switzerland
- Employees
- EFOI N/A
- NLSP N/A
- Industry
- EFOI Building Products
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- EFOI Consumer Discretionary
- NLSP Health Care
- Exchange
- EFOI Nasdaq
- NLSP Nasdaq
- Market Cap
- EFOI 6.6M
- NLSP 243.8M
- IPO Year
- EFOI 1994
- NLSP 2021
- Fundamental
- Price
- EFOI $1.32
- NLSP $4.55
- Analyst Decision
- EFOI
- NLSP
- Analyst Count
- EFOI 0
- NLSP 0
- Target Price
- EFOI N/A
- NLSP N/A
- AVG Volume (30 Days)
- EFOI 6.2K
- NLSP 33.1K
- Earning Date
- EFOI 11-07-2024
- NLSP 11-01-2024
- Dividend Yield
- EFOI N/A
- NLSP N/A
- EPS Growth
- EFOI N/A
- NLSP N/A
- EPS
- EFOI N/A
- NLSP N/A
- Revenue
- EFOI $6,118,000.00
- NLSP N/A
- Revenue This Year
- EFOI N/A
- NLSP N/A
- Revenue Next Year
- EFOI N/A
- NLSP N/A
- P/E Ratio
- EFOI N/A
- NLSP N/A
- Revenue Growth
- EFOI 38.67
- NLSP N/A
- 52 Week Low
- EFOI $1.14
- NLSP $4.08
- 52 Week High
- EFOI $2.90
- NLSP $29.84
- Technical
- Relative Strength Index (RSI)
- EFOI 52.26
- NLSP 40.59
- Support Level
- EFOI $1.21
- NLSP $4.38
- Resistance Level
- EFOI $1.38
- NLSP $5.64
- Average True Range (ATR)
- EFOI 0.07
- NLSP 0.47
- MACD
- EFOI 0.01
- NLSP 0.06
- Stochastic Oscillator
- EFOI 65.00
- NLSP 29.16
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. It serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, wall-packs, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. It generates a majority of its sales from Military maritime products in the United States.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.